Skip to main content
Premium Trial:

Request an Annual Quote

Kim Kelderman

Bio-Techne has hired Kim Kelderman as president of Diagnostics and Genomics, effective April 30. Based in California, Kelderman will lead Bio-Techne's diagnostics business, and drive and develop the company's initiatives in genomics and genomics-based diagnostics. He joins Bio-Techne from Thermo Fisher Scientific, where for the past three years he managed the platforms and content of the Genetic Sciences Division. In that position he was responsible for the instrumentation, software, consumables, and assays businesses, and brands including Applied Biosystems and legacy Affymetrix. Prior to being at Thermo Fisher, he was a segment leader at Becton Dickinson. 

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.